# ClinicalTrials.gov record NCT07338214

> PeptideScanner retained ClinicalTrials.gov record NCT07338214 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct07338214-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07338214-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07338214-petrelintide-v1.json
- Content SHA-256: `dd4c69c7f0a378ab5ffa0bf9bec668c78181a3b9b500345df4c015544c761ec4`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07338214 ([`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`](#source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07338214 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`](#source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07338214 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`](#source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`](#source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d))

## Sources

<a id="source-ctg-observation-nct07338214-2026-04-08-ee70b78b750d"></a>
- **ClinicalTrials.gov record NCT07338214 · retained source version 2026-04-08:ee70b78b750de2d906d9b43983d8d05515168ccdc89ef2bf4a818f4b0a007791** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07338214) (`ctg-observation-nct07338214-2026-04-08-ee70b78b750d`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07338214." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07338214-petrelintide-v1.json SHA-256: dd4c69c7f0a378ab5ffa0bf9bec668c78181a3b9b500345df4c015544c761ec4.